Lanadelumab for the prevention of hereditary angioedema attacks: A real‐world <scp>UK</scp> audit
Anthony D. Dorr, Charu Chopra, Tanya Coulter, John Dempster, Magdalena Dziadzio, Tariq El‐Shanawany, Tomaz Garcez, Mark Gompels, Richard Herriot, Rashmi Jain, Marcel Levi, Lorena Lorenzo, Inas Makki, Elizabeth Mapazire, Sai Murng, Sadia Noorani, Sinisa Savic, Cathal Steele, Christine Symons, Michael Tarzi, Patrick Yong, Sorena Kiani‐Alikhan
Abstract
Appendix S1: Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
Hereditary angioedemaAuditMedicineContent (measure theory)AngioedemaBusinessDermatologyAccountingMathematical analysisMathematicsCoagulation, Bradykinin, Polyphosphates, and AngioedemaUrticaria and Related ConditionsMast cells and histamine